Safety and efficacy of disease-modifying antirheumatic agents in rheumatoid arthritis and juvenile rheumatoid arthritis.
about
A qualitative interview study: patient accounts of medication use in early rheumatoid arthritis from symptom onset to early postdiagnosisImprovement in medication education in a pediatric subspecialty practice.Dietary supplementation with arachidonic acid increases arachidonic acid content in paw, but does not affect arthritis severity or prostaglandin E2 content in rat adjuvant-induced arthritis modelSuppressed wound healing in a patient with rheumatoid arthritis taking leflunomide (arava).
P2860
Safety and efficacy of disease-modifying antirheumatic agents in rheumatoid arthritis and juvenile rheumatoid arthritis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Safety and efficacy of disease ...... juvenile rheumatoid arthritis.
@ast
Safety and efficacy of disease ...... juvenile rheumatoid arthritis.
@en
type
label
Safety and efficacy of disease ...... juvenile rheumatoid arthritis.
@ast
Safety and efficacy of disease ...... juvenile rheumatoid arthritis.
@en
prefLabel
Safety and efficacy of disease ...... juvenile rheumatoid arthritis.
@ast
Safety and efficacy of disease ...... juvenile rheumatoid arthritis.
@en
P2860
P356
P1476
Safety and efficacy of disease ...... juvenile rheumatoid arthritis.
@en
P2093
Roy Fleischmann
P2860
P304
P356
10.1517/14740338.2.4.347
P407
P577
2003-07-01T00:00:00Z